bluebird bio Inc

bluebird bio Inc(BLUE)の株式分析

$4.970

0.000 (0.00%)終値時点

Loading chart…
高値
5.030
始値
4.740
出来高加重平均価格
4.89
出来高
1.25M
時価総額
—
安値
4.670
売買代金
6.09M
EV/EBITDA(TTM)
-2.09

bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA is used for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs).

www.bluebirdbio.com

アナリスト評価(18)

上値余地 +60.97%
買い
12 買い
5 中立
1 売り
現在: 4.97
安値
8.00
平均
8.00
高値
8.00

Barclays

2025-03-31

目標株価

$8

買い

JP Morgan

2025-02-24

目標株価

—

中立

Wells Fargo

2025-02-24

目標株価

$5

中立

Barclays

2024-12-31

目標株価

$40

買い

Barclays

2024-11-15

目標株価

$2

買い

バリュエーション指標

bluebird bio Inc(BLUE)の現在の予想PERは-0.38で、5年平均は-1.59です。

予想PER

割高
5年平均 P/E
-1.59
現在のP/E
-0.38
割高
-0.58
割安
-2.59

予想EV/EBITDA

適正
5年平均 EV/EBITDA
-1.75
現在のEV/EBITDA
-2.09
割高
-0.35
割安
-3.15

予想PSR

適正
5年平均 P/S
7.16
現在のP/S
0.14
割高
16.95
割安
-2.62

Alphio AI による BLUE の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%BLUE

$16.32

シナリオ価格

基

基本

基本 · 50%BLUE

$13.42

シナリオ価格

弱

弱気

弱気 · 25%BLUE

$9.17

シナリオ価格

イベントタイムライン

2025-12-08 (ET)

07:30:00

PepGen Appoints Joseph Vittiglio as Chief Business and Legal Officer

2025-06-02 (ET)

08:37:04

Bluebird Bio announces completion of sale to fund managed by Carlyle, SK

2025-05-20 (ET)

07:09:11

PepGen appoints Kasra Kasraian as CTO

2025-05-14 (ET)

08:57:08

Bluebird Bio, SK Capital Partners amend merger agreement

2025-05-05 (ET)

16:01:42

Carlyle, SK receive approvals to complete Bluebird Bio acquisition

ニュース

BLUE のよくある質問 — Alphio AI が回答

bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA is used for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs). It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).

18 analysts cover BLUE: 12 rate it Buy, 5 Hold and 1 Sell. The average price target is 8.00.

コミュニティ

もっと見る ↗
mothmosaic3919 時間前

#near I think this is clearly one of the stronger altcoins right now. After a small #btc bounce, I think it will break out to a new high. If BTC pulls back, we will likely sweep longs down to the blue zone, then resume the uptrend. Going long spot and adding in the blue zone is my approach.

もっと見る
alpha_baker2026/10/11

📅 October 11, 2026 | 10:17 PM PKT Hey Traders & Crypto Family! 👋 The weekend is ending, but the next altcoin move could bring fresh opportunities. I’m watching $S, $STRK, $2U2, $BLUE, and $CKB. The key is to identify real buying strength instead of chasing sudden pumps. 🔥 $S (Sonic) Sonic is on my watchlist as traders look for renewed momentum across altcoins. I’m watching trading volume, nearby resistance, and whether buyers can sustain the move. A confirmed breakout could improve the short-term outlook, while weak volume may signal a failed move. Patience is essential before considering an entry. ⚡ $STRK (Starknet) STRK deserves attention because sharp rallies can attract traders quickly. However, a strong green candle does not guarantee another rally. I’m watching whether price holds its breakout area and whether buying pressure remains consistent. If momentum weakens, profit-taking could trigger a pullback. Confirmation matters more than excitement. 👀 $2U2 For $2U2, the priority is checking the latest chart before making a directional prediction. Is trading volume increasing? Is price breaking resistance or facing repeated rejection? A breakout supported by strong volume would be more convincing than a sudden spike without follow-through. I prefer waiting for a clear signal rather than guessing. 💧 $BLUE BLUE needs careful monitoring of its support and resistance zones. If buyers defend support and volume improves, the setup could become more interesting. However, weakening momentum near resistance may indicate that sellers are returning. Always verify the correct token and trading pair before making a trading decision. 🚀 $CKB (Nervos Network) CKB has shown notable market activity, making it important to watch whether buyers can sustain the recovery. If price consolidates above support and volume remains healthy, further upside may be possible. However, sharp gains can also attract profit-taking. I’m focusing on price stability and confirmation instead of chasing a sudden pump. ⚡ MY STRATEGY I’m watching confirmation, volume, and support/resistance rather than blindly following green candles. Every coin has a different setup, and not every breakout is worth chasing. Pro Tip: Always check the latest Bitget chart before entering a trade. Protecting capital comes first, and no setup guarantees profits. dyor

もっと見る
gigakettle2026/10/11

🚨 TOP ALTCOIN GAINERS — Bulls Are Making Moves! 🚀 The altcoin market is heating up, with several tokens posting impressive gains. Here are three coins catching attention right now! 👀 🟢 1. BLUE/USDT 💰 Price: $0.01158 📈 Change: +26.42% 🔥 Leading this watchlist with the strongest percentage gain. 🟢 2. S/USDT 💰 Price: $0.05224 📈 Change: +19.57% ⚡ Strong upward momentum as traders watch for continuation. 🟢 3. TIA/USDT 💰 Price: $0.5825 📈 Change: +17.23% 🚀 Another strong mover worth watching for a potential breakout. 📊 Market Ranking 🥇 BLUE: +26.42% 🥈 S: +19.57% 🥉 TIA: +17.23% ⚠️ What to Watch: After sharp rallies, profit-taking and sudden pullbacks can happen. Watch trading volume, resistance levels, and whether prices can hold their recent gains before assuming the trend will continue. 🔥 Which one has the strongest potential for the next move — BLUE, S, or TIA? Educational purposes only. Not financial advice. $BLUE $S $TIA

もっと見る
alpha_baker2026/10/11

BLUE Is Up 66%..... Can Bulls Break $0.01557? 👀 $STRK $CHIP 👉$BLUE has surged 66.48% to around $0.01515, pushing close to its 24-hour high and resistance at $0.01557. The rally is impressive, but RSI readings above 95 indicate extremely overheated momentum, so a sharp pullback cannot be ruled out. 📊 A confirmed breakout above $0.01557 could open the way toward $0.01632. If buyers lose strength, the $0.01464 area may be the first level to watch for support. 🤝💎Dyor

もっと見る
登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める